| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773905 | Kidney International Reports | 2017 | 8 Pages |
Abstract
Together, our proof-of-principle results demonstrate that BLI-based urinary CXCL9 detection has potential as a point-of-care noninvasive biomarker to diagnose and guide therapy for ACR in kidney transplantation recipients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ilaria Gandolfini, Cynthia Harris, Michael Abecassis, Lisa Anderson, Oriol Bestard, Giorgia Comai, Paolo Cravedi, Elena Cremaschi, J. Andrew Duty, Sander Florman, John Friedewald, Gaetano La Manna, Umberto Maggiore, Thomas Moran, Giovanni Piotti,